Hardik Mody
机构：University of Central Florida, American Association of Colleges of Pharmacy, University of Florida, Kaiser Permanente San Francisco Medical Center
发表论文 58 篇 · 总被引 683 次 · h-index 14
代表论文
- Best Practices and Considerations for Clinical Pharmacology and Pharmacometric Aspects for Optimal Development of CAR‐T and TCR‐T Cell Therapies: An Industry Perspective (2023 · Clinical Pharmacology & Therapeutics · 被引 28)
- PK/PD and Bioanalytical Considerations of AAV-Based Gene Therapies: an IQ Consortium Industry Position Paper (2023 · The AAPS Journal · 被引 21)
- Clinical Pharmacology Perspective on Development of Adeno‐Associated Virus Vector‐Based Retina Gene Therapy (2024 · Clinical Pharmacology & Therapeutics · 被引 20)
- Clinical Pharmacology Considerations for the “ Off‐the‐Shelf ” Allogeneic Cell Therapies (2024 · Clinical Pharmacology & Therapeutics · 被引 12)
- Industry Perspective on First‐in‐Human and Clinical Pharmacology Strategies to Support Clinical Development of T‐Cell Engaging Bispecific Antibodies for Cancer Therapy (2024 · Clinical Pharmacology & Therapeutics · 被引 10)
- An IQ Consortium Perspective on Best Practices for Bioanalytical and Immunogenicity Assessment Aspects of CAR‐T and TCR‐T Cellular Therapies Development (2023 · Clinical Pharmacology & Therapeutics · 被引 10)